COVID-19 e Doença Cardiovascular Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?

Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?

Referência bibliográfica :

Panteleimon E Papakonstantinou, Josip A Borovac, Aleksandra Gąsecka, Dario Bongiovanni, Hanne Ehrlinder, Michela Giustozzi, William A E Parker, Rui Azevedo Guerreiro

Descrição sumária:

Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?

Outras sugestões